Literature DB >> 3822149

Serum lipids after stroke.

I Mendez, V Hachinski, B Wolfe.   

Abstract

To ascertain the appropriate time for detecting lipid abnormalities for prophylaxis, serial analyses of fasting serum lipoproteins were undertaken prospectively in men with cerebral infarction or transient ischemic attacks. Serum total cholesterol (T CHOL) and low density lipoprotein cholesterol (LDL CHOL) in cerebral infarction patients aged 50 to 69 were lowest on day 7, intermediate on day 1, and highest at 3 months, whereas very low density lipoprotein and high density lipoprotein cholesterol (HDL CHOL) changed little. The day 1 mean fasting serum HDL CHOL of cerebral infarct patients was significantly lower in subjects aged 50 to 59 than in those aged 60 to 69 (23 +/- 3 versus 42 +/- 5 mg/dl), and there was a corresponding higher ratio of T CHOL:HDL CHOL (12.7 +/- 4.5 versus 4.7 +/- 0.4, p less than 0.01). Mean HDL CHOL levels were low normal to low in patients aged 50 to 69 with transient ischemic attacks. Both serum cholesterol and triglyceride levels are initially decreased in patients aged 50 to 69 with cerebral infarction, whereas only cholesterol is decreased in patients 60 to 69 with transient ischemic attacks. Important lipoprotein abnormalities may be missed in the acute phase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3822149     DOI: 10.1212/wnl.37.3.507

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Subacute decline in serum lipids precedes the occurrence of primary intracerebral hemorrhage.

Authors:  Chia-Ling Phuah; Miriam R Raffeld; Alison M Ayres; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

Review 2.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

3.  Plasma lipoproteins in cortical infarction versus transient ischaemic attacks: a case control study.

Authors:  M C Boutron; M Giroud; P Gras; P Gambert; C Lallemant; C Milan; E Essayagh; R Dumas
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

4.  Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes.

Authors:  N Qizilbash; L Jones; C Warlow; J Mann
Journal:  BMJ       Date:  1991-09-14

Review 5.  Interventions in the management of serum lipids for preventing stroke recurrence.

Authors:  Bradley N Manktelow; John F Potter
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

6.  Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke.

Authors:  Kai-Hung Cheng; Jr-Rung Lin; Craig S Anderson; Wen-Ter Lai; Tsong-Hai Lee
Journal:  Front Neurol       Date:  2018-08-29       Impact factor: 4.003

7.  Association between low-density cholesterol change and outcomes in acute ischemic stroke patients who underwent reperfusion therapy.

Authors:  Ting Cui; Changyi Wang; Qiange Zhu; Anmo Wang; Xuening Zhang; Shucheng Li; Yuan Yang; Wenzuo Shang; Rong Peng; Bo Wu
Journal:  BMC Neurol       Date:  2021-09-16       Impact factor: 2.474

8.  Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: systematic review.

Authors:  Katiuscia Nardi; Didier Leys; Paolo Eusebi; Charlotte Cordonnier; Sophie Gautier; Hilde Hénon; Régis Bordet
Journal:  Cerebrovasc Dis Extra       Date:  2011-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.